Clearance of Antipyrine‐Dependence of Quantitative Liver Function
- 1 April 1974
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 4 (2), 129-134
- https://doi.org/10.1111/j.1365-2362.1974.tb02325.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The stimulant effect of drugs on indocyanine green clearance by the liverGut, 1972
- The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in manAmerican Heart Journal, 1971
- Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in manJCI Insight, 1969
- Zur Pharmakokinetik von Meprobamat bei chronischen Hepatopathien und ArzneimittelsuchtKlinische Wochenschrift, 1969
- PHENYLBUTAZONE AND ISONIAZID METABOLISM IN PATIENTS WITH LIVER DISEASE IN RELATION TO PREVIOUS DRUG THERAPYThe Lancet, 1968
- RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTIONThe American Journal of the Medical Sciences, 1964
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†JCI Insight, 1959
- Metabolism of Drugs in Subjects with Laennec’s CirrhosisPharmacology, 1959
- OBSERVATIONS ON THE METABOLIC TRANSFORMATION AND EFFECTS OF PHENYLBUTAZONE IN SUBJECTS WITH HEPATIC DISEASEThe American Journal of the Medical Sciences, 1954
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951